UNSPSC 41121709: Capillary or hematocrit tubes

UNSPSC 41121709 Capillary or hematocrit tubes is a Commodity code that encompasses laboratory reagents, consumables, and testing supplies used in state and local public health, environmental, and transportation laboratory operations. State and local procurement under this code reflects a mix of reagent purchasing (synthetic viral controls, wastewater surveillance reagents, microbiome particles, and genomic testing supplies), laboratory consumables (standards, gloves, wipes, septa, columns, and detector components), and sample collection and analysis services. The issuing bodies include state health and environmental departments (Colorado Department of Public Health and Environment, Texas Health and Human Services Commission, Department of State Health Services, Texas Department of Transportation), city governments (City of Arlington, Texas), and special-purpose state agencies (Texas General Land Office). Colorado's laboratory programs appear as repeat buyers, with multiple sole-source procurements for specialized reagents and equipment services across wastewater surveillance, genomic sequencing, and testing platforms.

Geographic activity centers on Texas and Colorado, with additional procurement visible in California, Mississippi, South Dakota, and multi-state water quality monitoring. Representative recent opportunities include the Texas Health and Human Services Commission's IFB HHS0018026 (posted September 24, 2026, due October 9, 2026) for standards, consumables, and instrument parts—GC columns, septa, UHPLC columns, protective gloves, and detector components—supporting drinking water analysis at an estimated fiscal 2026 value of $50,000 to $75,000; the City of Arlington's annual requirements contract for laboratory supplies and chemicals (posted August 19, 2026, due September 17, 2026) serving Laboratory Services and water treatment plants; and Colorado Department of Public Health and Environment sole-source procurements for Qiagen wastewater surveillance reagents and service ($3.14 million, posted May 22, 2026), Ceres Nanosciences microbiome reagents ($3.5 million, posted May 19, 2026), and Twist Bioscience synthetic viral assay controls ($2.3 million, posted May 19, 2026), all supporting public health surveillance and genomic sequencing operations. Sole-source authority dominates high-value acquisitions where specialized equipment, proprietary reagents, or platform-specific consumables create exclusive sourcing requirements.